LongBio Pharma (Suzhou) Co., Ltd. - B - H Shares Stock: price and insider trades · Hong Kong

LongBio Pharma (Suzhou) Co., Ltd. - B - H Shares is a listed company. Its directors and officers file their transactions with HKEX. 2 insiders have disclosed 2 filings since 18 October 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Insider buying of LongBio Pharma (Suzhou) Co., Ltd. - B - H Shares has been absent for the past year.

For context, the typical company on the same exchange (median of 750 companies) published 5 filings over the same period, against 2 filings here.

This summary is built from HKEX disclosures alone and does not predict where the share price will go.